AMZN
Amazon.com, Inc.
AMZN has the edge over SCI overall, supported by stronger modeled upside and stronger valuation.
SCI
Service Corporation International
SCI offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
SCI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Weak |
SCI's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is weak.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over SCI in the historical PE scenario, which offers more potential upside but is not a forecast.
SCI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $60.18 | -20% |
| Forward | 18x | $74.97 | — |
| Current | 19x | $74.97 | — |
| Fair | 20x | $80.86 | +7.9% |
| Expensive | 22x | $88.36 | +18% |
Historical ranges are pointers, not guarantees.
SCI's PE is in its fair range at 19x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
SCI Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect SCI's earnings to grow, with its revenue and profitability holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over SCI on earnings, with more consistent year-over-year improvement.
SCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.22 | +4.8% |
| Q3 2026 | $4.03 | +9.2% |
| Q2 2026 | $3.83 | +4.4% |
| Q1 2026 | $3.79 | +4.7% |
| Q4 2025 | $3.80 | +7.6% |
| Q3 2025 | $3.69 | +7% |
| Q2 2025 | $3.67 | +6.7% |
| Q1 2025 | $3.62 | +3.7% |
| Q4 2024 | $3.53 | 0% |
SCI earned $4.03 per share over the past year, up 9.2% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over SCI on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
SCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +4.6% |
| Q2 2026 | $1.1B | +3.6% |
| Q1 2026 | $1.1B | +2.1% |
| Q4 2025 | $1.1B | +1.7% |
| Q3 2025 | $1.1B | +4.4% |
| Q2 2025 | $1.1B | +3% |
| Q1 2025 | $1.1B | +2.8% |
| Q4 2024 | $1.1B | +3.5% |
SCI's revenue has grown year over year for 14 quarters in a row: $1.1B last quarter, up 4.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +1.4 points |
| Q2 2026 | 21% | -0.1 points |
| Q1 2026 | 22% | -1.2 points |
| Q4 2025 | 25% | +0.8 points |
| Q3 2025 | 21% | +0.4 points |
| Q2 2025 | 21% | -0.3 points |
| Q1 2025 | 23% | +1.2 points |
| Q4 2024 | 24% | +1.1 points |
SCI has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
SCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $197.4M | +31% |
| Q2 2026 | $142.9M | +71% |
| Q1 2026 | $253.9M | +9% |
| Q4 2025 | $87.2M | -43% |
| Q3 2025 | $150.7M | -7.5% |
| Q2 2025 | $83.4M | -17% |
| Q1 2025 | $233M | +66% |
| Q4 2024 | $151.8M | -17% |
SCI has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
SCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -1.1M shares |
| 1 year | -3% | -4.2M shares |
| 3 years | -9.9% | -15.1M shares |
| 5 years | -19% | -32.8M shares |
| Available history | -26% | -48.3M shares |
SCI has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $52.6M |
| Q2 2026 | $123.2M |
| Q1 2026 | $143.2M |
| Q4 2025 | $58.9M |
| Q3 2025 | $78.1M |
| Q2 2025 | $193.6M |
| Q1 2025 | $130.5M |
| Q4 2024 | $56.2M |
SCI spent $378M buying back its own shares over the past year, down 18% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over SCI on leverage, with a lower net debt burden relative to earnings.
SCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | High |
| Q2 2026 | 4.1x | High |
| Q1 2026 | 4.1x | High |
| Q4 2025 | 4.0x | High |
| Q3 2025 | 4.0x | Elevated |
| Q2 2025 | 4.0x | High |
| Q1 2025 | 3.9x | Elevated |
| Q4 2024 | 4.0x | Elevated |
SCI's net debt is about 4.0 years of its operating earnings (EBITDA), about the same as a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
SCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.2 | Neutral |
| Stochastic | 31.6 | Neutral |
SCI's weekly RSI is 43 (neutral) and its Stochastic is 32 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
SCI PE vs Consumer Cyclical Sector
| Metric | SCI | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 18x | 3.2% above |
| PE % | 34 | 47 | 13 pts below |
SCI has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over SCI on trend strength, trading above more of its moving averages.
SCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $77.7 | 3.5% below |
| 20 week MA | $80.2 | 6.5% below |
| 50 week MA | $79.7 | 5.9% below |
| 100 week MA | $79.5 | 5.7% below |
| 200 week MA | $74.6 | 0.5% above |
SCI has fallen below most of its moving averages, though it's still 0.5% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over SCI on returns for 2026, with the stronger performance.
SCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.1 | $48.7 | +5.6% |
| 2021 | $48.7 | $69.7 | +43% |
| 2022 | $69.7 | $70.2 | +0.8% |
| 2023 | $70.2 | $68.5 | -2.5% |
| 2024 | $68.5 | $80.8 | +18% |
| 2025 | $80.8 | $78.0 | -3.5% |
| 2026 YTD | $78.0 | $75.0 | -3.8% |
SCI has finished higher in four of the last six years. It's down 3.8% so far in 2026.